RVL Pharmaceuticals PLC
NASDAQ:RVLP

Watchlist Manager
RVL Pharmaceuticals PLC Logo
RVL Pharmaceuticals PLC
NASDAQ:RVLP
Watchlist
Price: 0.0024 USD 14.29% Market Closed
Updated: May 29, 2024

RVL Pharmaceuticals PLC
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

RVL Pharmaceuticals PLC
Total Other Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
RVL Pharmaceuticals PLC
NASDAQ:RVLP
Total Other Income
$7.5m
CAGR 3-Years
104%
CAGR 5-Years
75%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Total Other Income
-$149m
CAGR 3-Years
N/A
CAGR 5-Years
-14%
CAGR 10-Years
-54%
Pfizer Inc
NYSE:PFE
Total Other Income
-$5m
CAGR 3-Years
N/A
CAGR 5-Years
50%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Total Other Income
$1.5B
CAGR 3-Years
48%
CAGR 5-Years
41%
CAGR 10-Years
18%
Eli Lilly and Co
NYSE:LLY
Total Other Income
$456.1m
CAGR 3-Years
-32%
CAGR 5-Years
3%
CAGR 10-Years
20%

See Also

What is RVL Pharmaceuticals PLC's Total Other Income?
Total Other Income
7.5m USD

Based on the financial report for Dec 31, 2022, RVL Pharmaceuticals PLC's Total Other Income amounts to 7.5m USD.

What is RVL Pharmaceuticals PLC's Total Other Income growth rate?
Total Other Income CAGR 5Y
75%

Over the last year, the Total Other Income growth was 78%. The average annual Total Other Income growth rates for RVL Pharmaceuticals PLC have been 104% over the past three years , 75% over the past five years .